The Asia Pacific pacemaker market is expected to reach US$ 2,242.7 Mn in 2027 from US$ 1,030.5 Mn in 2018. The market is projected to grow with a CAGR of 9.2% from 2019-2027.
The growth in the Asia Pacific is characterized by growing geriatric population, increasing incidences of a cardiovascular, sedentary lifestyle, and high accessibility to advanced technologies, growing development of innovative and technologically advanced products and increasing healthcare expenditure
Growing obesity in this region is also likely to grow cardiovascular diseases. Malaysia has the highest obesity rate of 14 % in the South East Asia region, followed by Thailand with 8.8%. Moreover, the obesity rate in Australia and New Zealand is 26.8% and 28.3 % respectively. Furthermore, unhealthy diets are leading to overnutrition and obesity. The impact of fast food is being observed in some countries of the Asia Pacific region. According to UNICEF 2013 report, it estimated that 11 million children under 5 are overweight in the East Asia-Pacific region. Thus, these factors contribute to the growth of cardiovascular diseases and eventually lead to the growth of the pacemaker market.
In addition, during the year 2016 to 2019, various companies have made organic and inorganic growth strategies in the market there are operating. Some of the activities undertaken by the company, which have promoted its growth are product launches, acquisition, and partnership. The organic development strategy has been implemented increasing that have helped the growth of the companies and in turn, have brought about various changes in the market. For instance, in May 2018, Lepu Medical Technology (Beijing) Co Limited, a manufacturer from China, expanded its business into Indian market through an overseas subsidiary company, Lepucare (India) Vascular Solutions. Lepu Medical Technology (Beijing) Co. entered the Indian market through a subsidiary and is likely to explore opportunities for local manufacturing and collaborations.
Japan is expected to witness growth during the forecast owing to the factors such as rise in the geriatric population and product launches by the major market players in Japan is likely to enhance the growth of pacemaker market during the forecast period.
ASIA PACIFIC PACEMAKER MARKET– MARKET SEGMENTATION
Asia Pacific Pacemaker market – By Product Type
Asia Pacific Pacemaker market – By Technology
Asia Pacific Pacemaker market – By End User
By Geography
• Asia Pacific
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 1,030.5 Million |
| Market Size by 2027 | US$ 2,242.7 Million |
| CAGR (2019 - 2027) | 9.2% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Pacemakers Market is valued at US$ 1,030.5 Million in 2018, it is projected to reach US$ 2,242.7 Million by 2027.
As per our report Asia Pacific Pacemakers Market, the market size is valued at US$ 1,030.5 Million in 2018, projecting it to reach US$ 2,242.7 Million by 2027. This translates to a CAGR of approximately 9.2% during the forecast period.
The Asia Pacific Pacemakers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Pacemakers Market report:
The Asia Pacific Pacemakers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Pacemakers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Pacemakers Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)